News

February 6, 2020February 6, 2020

First Patient Dosed in Phase 2 Trial of Oral Treatment to Ease Inflammation in Parkinson’s

News

Alkahest announced the dosing of a first patient in the Phase 2 trial for its Parkinson’s therapy AKST4290, an oral tablet aiming to ease the inflammation that can aggravate disease symptoms. ... Read more

February 6, 2020February 6, 2020

Collaboration Formed to Develop New Radiochemicals for Diagnosing, Treating Brain Diseases

News

A collaborative effort between Fuzionaire Diagnostics, McGill University and The Neuro (Montreal Neurological Institute-Hospital) will foster the development of a new class of radioactive molecules — called radiochemicals — ... Read more

February 5, 2020February 5, 2020

Oral Treatment in Phase 2 Trial, NYX-458, Seen to Aid Cognition in Primate Model Study

News

Aptinyx‘s investigational oral compound NYX-458 was able to ease cognitive difficulties in a non-human primate model of Parkinson’s disease, including attention, working memory and executive thinking, a study reports. Its ... Read more

February 5, 2020February 5, 2020

Imaging Analysis Software QyScore Receives FDA Clearance

News

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Qynapse‘s QyScore, a software that aids in analyzing brain scans taken by magnetic resonance imaging (MRI). The ... Read more

February 4, 2020February 4, 2020

FDA Clears Way for Phase 2 Trial of AV-101 for Levodopa-Induced Dyskinesia

News

VistaGen Therapeutics will begin a Phase 2 clinical trial to evaluate its lead candidate AV-101 as a potential treatment to reduce dyskinesia (abnormal involuntary movements) induced by levodopa in ... Read more

February 4, 2020February 4, 2020

Parkinson’s Foundation Awards $30K to First 3 Winners of Physical Therapy Faculty Grants

News

The first three winners of the Parkinson’s Foundation’s new Physical Therapy Faculty Award will use their up to $10,000 grant for projects aimed at putting exercise to work in improving patients’ lives. ... Read more

February 3, 2020February 3, 2020

High Blood Levels of Urate May Help Protect Dopamine-Producing Neurons in Men With Parkinson’s, Study Suggests

News

High levels of urate in the blood may help preserve dopamine-producing neurons and be used as a biomarker of positive outcomes in men newly-diagnosed with Parkinson’s disease, a study ... Read more

February 3, 2020February 3, 2020

Mutation in ATP13A2 Gene Linked to Nerve Cell Health and Possibly Parkinson’s, Study Says

News

A mutation in the ATP13A2 gene disrupts the transport of polyamines — positively charged molecules that interact with DNA and proteins to control cell growth, survival, and proliferation — ... Read more

January 31, 2020January 31, 2020

Parkinson’s Foundation, Zelira Crafting Survey on Cannabis Use and Possible Benefits

News

Zelira Therapeutics, an Australia-based medical cannabis company, has partnered with the Parkinson’s Foundation to learn more about patients’ usage and understanding of medical cannabis and hemp-derived treatments. Zelira and the ... Read more

January 31, 2020January 31, 2020

High Blood Levels of Liver Enzyme Linked to Sex-specific Parkinson’s Risk in Korean Study

News

Elevated blood levels of the liver enzyme gamma-glutamyltransferase (GGT), a marker for liver disease, was found to be associated with an increased risk of Parkinson’s disease in Korean women ... Read more

Pin It on Pinterest